{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T05:11:03Z","timestamp":1790053863639,"version":"4.0.1"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,3]]},"abstract":"<jats:p>Benzodiazepine use and dependence are on the rise as well as the number of deaths attributable to the combination of opioids and benzodiazepines. Anxiety, the most frequent condition for which benzodiazepines are prescribed, occurs commonly, and is increasingly noted to coincide with pregnancy. Use of both benzodiazepine anxiolytics and anxiety in pregnancy is associated with preterm delivery and low birth weight. Short-term neonatal effects of hypotonia, depression, and withdrawal are described but long-term sequelae, if any, are poorly understood. Benzodiazepines are associated with physical dependence and withdrawal symptoms which can be serious. To avoid withdrawal, tapering off these medications is recommended. What is known about the pharmacology and pharmacokinetics, pregnancy implications, tapering schedules, and alternative strategies for anxiety are discussed.<\/jats:p>","DOI":"10.1097\/grf.0000000000000417","type":"journal-article","created":{"date-parts":[[2019,1,21]],"date-time":"2019-01-21T03:55:34Z","timestamp":1548042934000},"page":"156-167","source":"Crossref","is-referenced-by-count":56,"title":["Benzodiazepines in Pregnancy"],"prefix":"10.1097","volume":"62","author":[{"given":"JAYE M.","family":"SHYKEN","sequence":"first","affiliation":[{"name":"St. Louis University School of Medicine, St. Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SHILPA","family":"BABBAR","sequence":"additional","affiliation":[{"name":"St. Louis University School of Medicine, St. Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SHAWETA","family":"BABBAR","sequence":"additional","affiliation":[{"name":"Kaiser Permanente, Denver, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ALICIA","family":"FORINASH","sequence":"additional","affiliation":[{"name":"St. Louis College of Pharmacy, St. Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230911","doi-asserted-by":"crossref","first-page":"686","DOI":"10.2105\/AJPH.2016.303061","article-title":"Increasing benzodiazepine prescriptions and overdose mortality in the United States","volume":"106","author":"Bachhuber","year":"2016","journal-title":"Am J Public Health"},{"key":"R4-20230911","doi-asserted-by":"crossref","first-page":"j760","DOI":"10.1136\/bmj.j760","article-title":"Association between concurrent use of prescription opioids and benzodiazepines and overdose: retrospective analysis","volume":"356","author":"Sun","year":"2017","journal-title":"BMJ"},{"issue":"NoRR-1","key":"R5-20230911","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6501e1","article-title":"CDD guideline for prescribing opioids for chronic pain\u2014United States, 2016","volume":"65","author":"Dowell","year":"2016","journal-title":"MMWR Recomm Rep"},{"key":"R6-20230911","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1192\/bjp.bp.116.187179","article-title":"Prevalence of antenatal and postnatal anxiety: systematic review and meta-analysis","volume":"210","author":"Dennis","year":"2017","journal-title":"Br J Psych"},{"key":"R7-20230911","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/1471-2393-14-242","article-title":"Patterns of psychotropic medicine use in the pregnancy in the United States from 2006 to 2011 among women with private insurance","volume":"14","author":"Hanley","year":"2014","journal-title":"BMC Pregnancy Childbirth"},{"key":"R8-20230911","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jsat.2017.01.011","article-title":"Substance use, treatment, and demographic characteristics of pregnant women entering treatment of opioid use disorder differ by United States census region","volume":"76","author":"Hand","year":"2017","journal-title":"J Subst Abuse Treat"},{"key":"R9-20230911","first-page":"214","article-title":"Benzodiazepine pharmacology and central nervous system-mediated effects","volume":"13","author":"Griffin","year":"2013","journal-title":"Oschsner J"},{"key":"R12-20230911","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.drugalcdep.2014.02.014","article-title":"Comparison of toxicity associated with nonmedical use of benzodiazepines with buprenorphine or methadone","volume":"138","author":"Lee","year":"2014","journal-title":"Drug Alcohol Depend"},{"key":"R16-20230911","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s11920-015-0642-5","article-title":"Withdrawing benzodiazepines in patients with anxiety disorders","volume":"18","author":"Lader","year":"2016","journal-title":"Curr Psychiatry Rep"},{"key":"R17-20230911","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.ajog.2014.10.1106","article-title":"A review of sleep-promoting medications used in pregnancy","volume":"212","author":"Okun","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"R18-20230911","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S1701-2163(16)34772-7","article-title":"The fetal safety of benzodiazepines: an updated meta-analysis","volume":"33","author":"Enato","year":"2011","journal-title":"J Obstet Gynaecol Can"},{"key":"R19-20230911","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.genhosppsych.2012.09.003","article-title":"Benzodiazepine exposure in pregnancy and risk of major malformations: a critical overview","volume":"35","author":"Bellantuaono","year":"2013","journal-title":"Gen Hosp Psych"},{"key":"R20-20230911","doi-asserted-by":"crossref","first-page":"e002166","DOI":"10.1136\/bmjopen-2012-002166","article-title":"Combined use of selective serotonin reuptake inhibitors and sedatives\/hypnotics during pregnancy: risk of relatively severe congenital malformations or cardiac defects. A register study","volume":"3","author":"Reis","year":"2013","journal-title":"BMJ Open"},{"key":"R21-20230911","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1002\/pds.1457","article-title":"Use of benzodiazepines and benzodiazepine receptor agonists during pregnancy: neonatal outcome and congenital malformations","volume":"16","author":"Wikner","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R22-20230911","doi-asserted-by":"crossref","first-page":"e12309","DOI":"10.1111\/appy.12309","article-title":"Maternal exposure to benzodiazepine and risk of preterm birth and low birth weight: a case-control study using a claims database in Japan","volume":"10","author":"Ogawa","year":"2018","journal-title":"Asia Pac Psychiatry"},{"key":"R23-20230911","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.4088\/JCP.17r12011","article-title":"Maternal anxiety during pregnancy and the association with adverse perinatal outcomes: systematic review and meta-analysis","volume":"79","author":"Grigoriadis","year":"2018","journal-title":"J Clin Psychiatry"},{"key":"R24-20230911","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1001\/jamapsychiatry.2017.2733","article-title":"Association of panic disorder, generalized anxiety disorder and benzodiazepine treatment during pregnancy with adverse birth outcomes","volume":"74","author":"Yonkers","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"R25-20230911","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.genhosppsych.2018.05.010","article-title":"Obstetrical and neonatal outcomes after benzodiazepine exposure during pregnancy: results from a prospective registry of women with Psychiatric disorders","volume":"53","author":"Freeman","year":"2018","journal-title":"Gen Hosp Psychiatry"},{"key":"R26-20230911","first-page":"1001","article-title":"ACOG Practice Bulletin: clinical management guidelines for obstetrician-gynecologists number 92, April 2008 (reaffirmed 2018). Use of psychiatric medications during pregnancy and lactation","volume":"111","year":"2008","journal-title":"Obstet Gynecol"},{"key":"R27-20230911","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1136\/bmj.282.6270.1106","article-title":"Effect of maternal lorazepam on the neonate","volume":"282","author":"Whitelaw","year":"1981","journal-title":"Br Med J"},{"key":"R28-20230911","doi-asserted-by":"crossref","first-page":"j3326","DOI":"10.1136\/bmj.j3326","article-title":"Risk of neonatal drug withdrawal after intrauterine co-exposure to opioids and psychotropic medications: cohort study","volume":"358","author":"Huybrechts","year":"2017","journal-title":"BMJ"},{"key":"R29-20230911","doi-asserted-by":"crossref","first-page":"396.e1","DOI":"10.1016\/j.ajog.2008.06.088","article-title":"Predicting length of treatment for neonatal abstinence syndrome in methadone-exposed neonates","volume":"199","author":"Seligman","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"R30-20230911","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ntt.2017.02.005","article-title":"Prenatal exposure to anxiolytic and hypnotic medication in relation to behavioral problems in childhood: a population-based cohort study","volume":"61","author":"Radojcic","year":"2017","journal-title":"Neurotoxicol Teratol"},{"key":"R31-20230911","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1007\/s00228-014-1738-2","article-title":"Drug-induced adverse reactions via breastfeeding: a descriptive study in the French Pharmacovigilance Database","volume":"70","author":"Soussan","year":"2014","journal-title":"Eur J Clin Pharmacol"},{"key":"R32-20230911","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1080\/09595230100100615","article-title":"In-patient benzodiazepine withdrawal: comparison of fixed and symptom-triggered taper methods","volume":"22","author":"McGregor","year":"2003","journal-title":"Drug Alcohol Rev"},{"key":"R33-20230911","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1192\/bjp.182.6.498","article-title":"Tapering off long-term benzodiazepine use with or without group cognitive-behavioural therapy: three-condition, randomized controlled trial","volume":"182","author":"Voshaar","year":"2003","journal-title":"Br J Psychiatry"},{"key":"R34-20230911","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1192\/bjp.158.4.511","article-title":"A double-blind comparison of the erects of gradual withdrawal of lorazepam, diazepam and bromazepam in benzodiazepine dependence","volume":"158","author":"Murphy","year":"1991","journal-title":"Br J Psychiatry"},{"key":"R35-20230911","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0740-5472(91)90022-3","article-title":"Detoxification from benzodiazepines: schedules and strategies","volume":"8","author":"Alexander","year":"1991","journal-title":"J Subst Abuse Treat"},{"key":"R36-20230911","first-page":"22","article-title":"Benzodiazepines: sensible prescribing in light of the risks","volume":"17","author":"Weber","year":"2018","journal-title":"Curr Psychiatry"},{"key":"R39-20230911","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00737-013-0388-1","article-title":"Managing benzodiazepine withdrawal during pregnancy: case-based guidelines","volume":"17","author":"Gopalan","year":"2014","journal-title":"Ment Arch Womens Health"},{"key":"R41-20230911","article-title":"Generalised anxiety disorder","volume":"1002","author":"Gale","year":"2007","journal-title":"BMJ Clin Evid"},{"key":"R42-20230911","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007559.pub2","article-title":"Mind-body interventions during pregnancy for preventing or treating women\u2019s anxiety","author":"Marc","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"R44-20230911","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1552-6909.2009.01023.x","article-title":"The effects of mindfulness-based yoga during pregnancy on maternal psychological and physical distress","volume":"38","author":"Beddoe","year":"2009","journal-title":"J Obstet Gynecol Neonatal Nurs"},{"key":"R45-20230911","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.ctcp.2013.06.003","article-title":"Effect of integrated yoga on anxiety, depression & well being in normal pregnancy","volume":"19","author":"Satyapriya","year":"2013","journal-title":"Complement Ther Clin Pract"},{"key":"R46-20230911","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ijgo.2008.11.013","article-title":"Effect of integrated yoga on stress and heart rate variability in pregnant women","volume":"104","author":"Satyapriya","year":"2009","journal-title":"Int J Gynaecol Obstet"},{"key":"R47-20230911","first-page":"CC05","article-title":"Effect of mindfulness meditation on perceived stress scores and autonomic function tests of pregnant Indian women","volume":"10","author":"Muthukrishnan","year":"2016","journal-title":"J Clin Diagn Res"}],"updated-by":[{"DOI":"10.1097\/grf.0000000000000429","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000}}],"container-title":["Clinical Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00003081-201903000-00018","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T20:14:16Z","timestamp":1694463256000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003081-201903000-00018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/grf.0000000000000417","relation":{},"ISSN":["0009-9201"],"issn-type":[{"value":"0009-9201","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]}}}